Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX: MCRO)
Egypt flag Egypt · Delayed Price · Currency is EGP
2.530
-0.070 (-2.69%)
At close: Dec 19, 2024

EGX: MCRO Ratios and Metrics

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
1,4431,6821,870--
Market Cap Growth
-28.35%-10.06%---
Enterprise Value
1,5941,8151,944--
Last Close Price
2.532.953.18--
PE Ratio
--10.76--
Forward PE
-10.0610.06--
PS Ratio
5.623.202.56--
PB Ratio
28.8617.834.04--
P/TBV Ratio
46.2625.104.55--
P/FCF Ratio
47.82-14.43--
P/OCF Ratio
28.62-13.86--
PEG Ratio
0.420.420.42--
EV/Sales Ratio
6.243.452.66--
EV/EBITDA Ratio
--8.17--
EV/EBIT Ratio
--8.30--
EV/FCF Ratio
52.85-15.00--
Debt / Equity Ratio
5.502.400.440.270.26
Debt / EBITDA Ratio
--0.830.470.35
Debt / FCF Ratio
9.12-1.582.201.64
Asset Turnover
0.340.771.021.21-
Inventory Turnover
1.451.641.642.15-
Quick Ratio
0.620.291.181.191.18
Current Ratio
1.291.082.002.312.06
Return on Equity (ROE)
-169.61%-97.85%42.36%48.77%-
Return on Assets (ROA)
-32.17%-16.72%20.53%25.81%-
Return on Capital (ROIC)
-50.29%-23.07%26.08%33.12%-
Earnings Yield
-30.43%-16.21%9.29%--
FCF Yield
2.09%-2.64%6.93%--
Dividend Yield
0.00%-3.36%--
Payout Ratio
0.00%-23.01%31.65%54.65%
Buyback Yield / Dilution
-0.27%1.46%0.88%--
Total Shareholder Return
-0.27%1.46%4.24%--
Source: S&P Capital IQ. Standard template. Financial Sources.